Treatment of Pruritus Secondary to Liver Cirrhosis

Stepwise Treatment Algorithm

The American Association for the Study of Liver Diseases recommends cholestyramine as first-line therapy for pruritus secondary to liver cirrhosis due to its favorable safety profile, followed by rifampicin as second-line treatment if cholestyramine is ineffective or not tolerated 1, 2, 3
Cholestyramine works by binding bile salts in the gut lumen, preventing their absorption in the terminal ileum, and should be taken separately from other medications by at least 4 hours to prevent binding and loss of efficacy 3, 4
Rifampicin is recommended as second-line therapy when cholestyramine fails or is not tolerated, with a starting dose of 150mg daily and gradual increase to a maximum of 600mg daily if needed, and has strong evidence supporting its efficacy in reducing hepatic pruritus 2, 3, 4, 5

For patients resistant to standard therapies, consider selective serotonin reuptake inhibitors (SSRIs) other than sertraline, and experimental physical approaches in specialized centers, such as extracorporeal albumin dialysis, plasmapheresis, bile duct drainage, and ultraviolet (UV) light therapy 1, 3, 6
Liver transplantation is highly effective for controlling cholestatic itch but should only be considered when all available interventions have proven ineffective 1, 3

Gabapentin is not recommended for hepatic pruritus due to lack of efficacy in clinical trials 1, 4
Antihistamines have limited efficacy for cholestatic pruritus but may provide non-specific relief through sedative properties 1, 4
Ondansetron has shown inconsistent results in clinical trials and is not routinely recommended 4

Use visual analogue scales to help assess response to interventions, and monitor liver function tests regularly when using rifampicin due to risk of hepatotoxicity 3
Evaluate for presence of dominant biliary strictures in patients with worsening pruritus, increasing bilirubin levels, or progressive bile duct dilation on imaging 3